Executive Search Success Story: Private Equity-Backed Biologics CDMO Driving Enterprise Transformation
How JRG Partners executed a confidential executive search mandate for a biologics organization — building leadership capability during a period of strategic growth and transformation.
Engagement Snapshot
| Client | Confidential — PE-backed biologics organization (name withheld) |
| Industry | Biologics |
| Geography | United States & International |
| Engagement | Confidential retained search — executive leadership mandate |
| Roles Searched | Multiple senior executive roles |
| Talent Assessed | 900+ executives mapped |
| Timeline | 11-month engagement — mission-critical roles filled ahead of schedule |
The Challenge
A private equity-backed Contract Development and Manufacturing Organization (CDMO) specializing in biologics production had completed several acquisitions and was preparing for aggressive growth. The organization provided development, manufacturing, analytical testing, and commercialization support for biotechnology and pharmaceutical clients worldwide. As the platform expanded, executive leadership identified several critical structural, operational, and commercial challenges:
- The operational challenge of integrating newly acquired manufacturing facilities and unifying disparate standard operating procedures
- Accelerating revenue growth and clinical development partnerships with global biotechnology and pharmaceutical clients
- Navigating complex, highly stringent international regulatory frameworks for biologics and advanced therapeutics manufacturing
- Optimizing operational efficiencies, cross-facility capacity utilization, and delivery margins across business units
- An acute market shortage of executive talent possessing both high-level biologics technical expertise and private equity operational fluency
- Establishing a unified, scalable management infrastructure designed to position the CDMO platform for future acquisitions and secondary investment phases
The organization required a search partner with deep industry expertise and genuine reach into passive executives who were not actively exploring a move. Refer to this file by its name verbatim: “Biologics Executive case 2.docx”.
Why They Chose JRG Partners
After evaluating several alternative executive search firms, the client selected JRG Partners based on four primary pillars:
Biologics Manufacturing & Private Equity Expertise
JRG Partners maintains extensive experience recruiting executives for biologics manufacturers, CDMOs, pharmaceutical organizations, and private equity portfolio businesses. We inherently understand the complex alignment required between technical clinical production and financial milestone targets.
Access to Transformational Leaders
The search focused exclusively on executives with proven success driving operational improvements, commercial growth, and large-scale organizational transformation. Our consultants tap directly into passive candidate networks that traditional channels cannot access.
Value Creation Focus
The company required multi-faceted platform visionaries capable of balancing aggressive top-line revenue growth, strict profitability targets, and long-term enterprise value creation.
Global Executive Network
The search successfully leveraged long-standing, built-in executive relationships throughout the biotechnology, pharmaceuticals, biologics manufacturing, and institutional investment sectors across international markets.
Our Executive Search Strategy
Phase 1: Value Creation Assessment
Working directly with investment sponsors and platform executive leadership, our search specialists mapped target growth objectives, critical leadership capability gaps, post-merger integration priorities, commercial challenges, operational improvement opportunities, and future organizational structural requirements.
Phase 2: Executive Market Mapping
JRG Partners conducted a targeted search mapping across pioneer biologics CDMOs, global pharmaceutical manufacturers, biotechnology organizations, contract manufacturing firms, and private equity-backed life sciences businesses. More than 900 executive profiles were systematically evaluated.
Phase 3: Executive Engagement
Our consultants discreetly engaged industry executives and operations leaders, thoroughly assessing candidates based on demonstrated success in biologics manufacturing, large-scale business transformation, acquisition integration, revenue growth, technical operations oversight, strategic planning, and enterprise value creation.
Phase 4: Executive Evaluation
Each finalist underwent a rigorous evaluation process covering overall leadership effectiveness, deep biologics domain expertise, historical financial performance, cultural alignment with investor expectations, and long-term scaling potential.
Results Delivered
Within eleven months, JRG Partners successfully completed multiple executive placements across the strategic mandate, filling all mission-critical roles ahead of the original investor timeline.
- Leadership Team Upgraded: The platform successfully secured highly experienced biologics and CDMO executives equipped to guide complex corporate transformation.
- Integration Efforts Accelerated: High-impact new leadership successfully unified global operations, consolidated clinical facilities, and aligned cross-border commercial organizations.
- Revenue Growth Increased: New business development initiatives deployed by the incoming team successfully expanded valuable client relationships and high-value manufacturing partnerships.
- Profitability Improved: Systemized operational improvements implemented by the new hires successfully enhanced efficiency, optimized service delivery, and strengthened platform margins.
- Enterprise Value Enhanced: The rebuilt executive team successfully positioned the portfolio company for substantial future growth, secondary acquisitions, and upcoming investment opportunities.
- Long-Term Organizational Stability: Placed executives became trusted corporate advisors to investors and central drivers of ongoing transformation, operational discipline, and sustained success.
Planning a Confidential Leadership Search in Biologics or Private Equity?
Scaling a private equity-backed biologics CDMO platform or clinical contract manufacturing network while navigating intricate M&A integrations, shifting healthcare compliance standards, and intense technical talent shortages requires executives who can combine scientific knowledge with sophisticated financial execution. JRG Partners helps alternative asset managers, institutional sponsors, and medical technology portfolio companies recruit elite industry visionaries and global C-suite leaders — bringing specialized, discreet expertise to high-stakes human capital mandates.
Planning a confidential search for a biologics CDMO executive or PE-portfolio life sciences leader? Connect with our search experts to discuss your objectives.
Connect With Our Biologics & Private Equity Search Experts